Breath Test System - Carbon Monoxide (CO) Detection

A medical device used to measure nitric oxide and carbon dioxide levels in human exhaled breath. It supports both oral and nasal breathing modes with a measurement range of 1ppb to 3500ppb, enabling detection of airway inflammation and respiratory conditions.

System for detecting nitric oxide and carbon dioxide levels in human breath samples. Supports both oral and nasal breathing modes with measurement range of 1ppb to 3500ppb. Used for non-invasive monitoring of respiratory and circulatory parameters.

A device specialized in detecting and measuring biomarkers present in exhaled breath. This technology identifies specific compounds in exhaled air to provide diagnostic information about patient health conditions.

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

Nanoparticle-based exhaled breath analysis system for disease screening and biomarker detection. Enables non-invasive respiratory and systemic disease evaluation. Integrated analysis algorithms for automated interpretation.

A breath testing device designed for clinics, pharmacies, health screening centers, nursing homes, and community settings. It uses the same gas detection technology as hospital systems with interconnected diagnostic and treatment services, enabling hierarchical diagnosis and treatment of chronic respiratory diseases and cardiopulmonary health screening. It provides FeNO/CaNO/FeCO/FnNO testing for cough and asthma patients to optimize medication selection, reduce acute exacerbations and emergency hospitalization, and for susceptible populations for risk warning and disease prevention.

A breath analysis device designed for clinics, pharmacies, health check centers, nursing homes, and community settings using the same gas detection technology as hospital systems. The TM series performs FeNO/CaNO/FeCO/FnNO testing for respiratory chronic disease tiered diagnosis and heart-lung health screening, helping optimize drug selection and reduce acute exacerbations, emergency hospitalizations, and lung cancer risk.

Breathalyzer device utilizing electrochemical sensors for precise alcohol detection and quantification. Features real-time breath analysis with anti-cheating mechanisms, integrated display, and connectivity options (Bluetooth, USB, serial). Applications include personal alcohol assessment, driver monitoring programs, and workplace safety compliance. Supports facial recognition and cloud-based data management.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.

Smokerlyzer® Range comprises portable breath carbon monoxide (CO) devices designed to measure airway CO levels for smoking cessation support and biochemical verification of smoking status. These non-invasive diagnostic instruments provide real-time feedback to patients and clinicians, serving as motivational aids during smoking cessation programs and enabling objective progress monitoring.

Breath test card for non-invasive diagnostic screening and monitoring of respiratory conditions. Single-use disposable device that captures and analyzes breath samples to detect biomarkers associated with various clinical conditions. Designed for point-of-care and laboratory settings with rapid turnaround results.

In vitro diagnostic devices for breath testing applications. Supports various clinical assessments through non-invasive breath sample collection and analysis.